Literature DB >> 9602254

What is the role of erythropoietin in patients with solid tumours?

A Maraveyas, R Pettengell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9602254     DOI： 10.1023/a:1008273032715

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

Review 1.  Predictors of response to erythropoiesis-stimulating agents (ESA) in cancer patients: the role of baseline serum epoetin level.

Authors:  Jaime Sanz Ortiz
Journal:  Clin Transl Oncol       Date:  2008-08       Impact factor: 3.405

2.  Darbepoetin versus epoetin alfa for the correction of anemia in cancer patients receiving radiotherapy or chemoradiotherapy treatment.

Authors:  Pilar Ma Samper Ots; Concepción López Carrizosa; Aurora Rodríguez Pérez; Juan de Dios Saez Garrido; José Ma Delgado Pérez
Journal:  Clin Med Oncol       Date:  2008-05-19

3.  A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy.

Authors:  J Glaspy; J S Jadeja; G Justice; J Kessler; D Richards; L Schwartzberg; J Rigas; D Kuter; D Harmon; D Prow; G Demetri; D Gordon; J Arseneau; A Saven; H Hynes; R Boccia; J O'Byrne; A B Colowick
Journal:  Br J Cancer       Date:  2001-04       Impact factor: 7.640

4.  Pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in cancer patients: preliminary report.

Authors:  A C Heatherington; J Schuller; A J Mercer
Journal:  Br J Cancer       Date:  2001-04       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.